Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

RISK OF PARKINSON'S DISEASE (PD) IN PATIENTS TAKING ADRENERGIC DRUG TREATMENTS

Conference paper

Stacey J. et al, (2018), VALUE IN HEALTH, 21, S329 - S329

Machine learning for predicting lifespan-extending chemical compounds

Journal article

Newby D. et al, (2017), Aging, 9

Prediction of drug-induced phospholipidosis

Conference paper

Newby D. et al, (2016), TOXICOLOGY LETTERS, 258, S284 - S284

Prediction of drug-induced phospholipidosis

Conference paper

Newby D. et al, (2016), TOXICOLOGY LETTERS, 258, S284 - S284

Comparing multilabel classification methods for provisional biopharmaceutics class prediction.

Journal article

Newby D. et al, (2015), Mol Pharm, 12, 87 - 102

Pre-processing feature selection for improved C&RT models for oral absorption.

Journal article

Newby D. et al, (2013), J Chem Inf Model, 53, 2730 - 2742

Coping with unbalanced class data sets in oral absorption models.

Journal article

Newby D. et al, (2013), J Chem Inf Model, 53, 461 - 474

The impact of training set data distributions for modelling of passive intestinal absorption.

Journal article

Ghafourian T. et al, (2012), Int J Pharm, 436, 711 - 720